Development of DNA Vaccines against Hemolytic-Uremic Syndrome in a Murine Model
AUTOR(ES)
Capozzo, Alejandra V. E.
FONTE
American Society for Microbiology
RESUMO
Shiga toxin type 2 (Stx2) produced by Escherichia coli O:157H7 can cause hemolytic-uremic syndrome in children, a disease for which there is neither a vaccine nor an effective treatment. This toxin consists of an enzymatically active A subunit and a pentameric B subunit responsible for the toxin binding to host cells, and also found to be immunogenic in rabbits. In this study we developed eukaryotic plasmids expressing the B subunit gene of Stx2 (pStx2B) and the B subunit plus the gene coding for the A subunit with an active-site deletion (pStx2ΔA). Transfection of eukaryotic cells with these plasmids produced proteins of the expected molecular weight which reacted with specific monoclonal antibodies. Newborn and adult BALB/c mice immunized with two intramuscular injections of each plasmid, either alone or together with the same vector expressing the granulocyte and monocyte colony-stimulating factor (pGM-CSF), elicited a specific Th1-biased humoral response. The effect of pGM-CSF as an adjuvant plasmid was particularly notable in newborn mice and in pStx2B-vaccinated adult mice. Stx2-neutralizing activity, evaluated in vitro on VERO cell monolayers, correlated with in vivo protection. This is the first report using plasmids to induce a neutralizing humoral immune response against the Stx2.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=162006Documentos Relacionados
- Escherichia coli infections and hemolytic-uremic syndrome
- Escherichia coli infections and hemolytic-uremic syndrome
- Adult hemolytic-uremic syndrome and bone marrow necrosis.
- E. coli, antibiotics and hemolytic-uremic syndrome in children
- Enterohemorrhagic Escherichia coli associated with hemolytic-uremic syndrome in Chilean children.
